Ketamine's double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant OCD - A case series.
Indian journal of psychiatry June 1, 2025 Suparna Kumar, Jigyansa Ipsita Pattnaik, Udit Kumar Panda et al. 3 citations
Ketamine infusion (0.5 mg/kg) every other day for six sessions led to progressive improvement in three of four adolescents with treatment-resistant obsessive-compulsive disorder, with benefits maintained at two-month follow-up. One patient developed ketamine-induced psychosis. Ketamine shows promise as an adjuvant treatment for adolescent OCD, but psychomimetic risks require careful consideration.